Skip to content
Back to library
Weight-loss medications

How Do I Use Mounjaro? A Patient's Guide to Dosing, Injections, and Safety

Learn how to correctly use Mounjaro (tirzepatide), including injection sites, the step-up dosing schedule, handling missed doses, and storage guidelines.

Direct answer

Mounjaro (tirzepatide) is administered as a single-use subcutaneous injection given once every week, at any time of day, with or without food. You inject it into the fat layer under your skin—specifically in your abdomen, thigh, or the upper arm if a caregiver assists you. Treatment always starts at a low dose of 2.5 mg weekly for the first 4 weeks, after which your doctor will gradually increase the dose in 2.5 mg increments every 4 weeks until you reach your target weekly maintenance dose.

Where and how do I inject Mounjaro?

Mounjaro is given by subcutaneous injection, meaning it goes into the fatty layer under your skin, not into a muscle or vein. You can inject it into three main areas:

  • Your abdomen (stomach area), keeping at least 2 inches away from your belly button.
  • The front of your thighs.
  • The back of your upper arm (this site is best used if a caregiver or family member is administering the injection for you).

It is important to rotate your injection site each week. Rotating the site reduces local skin irritation and tissue soreness. You can use the same general area of the body (such as your abdomen), but choose a different spot within that area each week. You may inject Mounjaro at any time of day, regardless of when you eat.

What is the standard Mounjaro dosing schedule?

To help your stomach adjust and minimize gastrointestinal side effects like nausea, vomiting, diarrhea, or constipation, Mounjaro uses a mandatory stepwise dose titration schedule:

PhaseWeekly DoseDurationClinical Purpose
Initiation2.5 mgWeeks 1–4Initiates treatment and builds GI tolerability (not a therapeutic maintenance dose).
First Step-Up5 mgWeeks 5–8Initial therapeutic maintenance dose.
Escalation+2.5 mg every 4 weeksMinimum 4 weeks per dose levelIncreased as needed for glycemic or weight goals (7.5 mg, 10 mg, 12.5 mg).
Maximum Dose15 mgLong-term maintenanceMaximum approved weekly dose.

The standard maintenance doses evaluated in clinical trials are 5 mg, 10 mg, or 15 mg once weekly. If you experience bothersome stomach side effects during an increase, your physician may advise remaining at a lower dose for longer before attempting to step up again.

What should I do if I miss a dose?

If you miss a dose of Mounjaro, what you should do depends on how much time has passed:

  • If 4 days (96 hours) or less have passed: Administer the missed dose as soon as you remember. After that, resume your normal weekly dosing day.
  • If more than 4 days have passed: Skip the missed dose completely and take your next dose on your regularly scheduled injection day.

Never take two doses of Mounjaro within 72 hours (3 days) of each other. If you need to change the day of the week you take your injection, you may do so as long as there are at least 72 hours between doses.

How should Mounjaro be stored?

Proper storage ensures the medication remains safe and effective:

  • Refrigeration: Store Mounjaro in the refrigerator between 2°C to 8°C (36°F to 46°F) in its original carton to protect it from light.
  • Room Temperature: Mounjaro can be left at room temperature (up to 30°C or 86°F) for up to 21 total days if needed.
  • Freezing: Do not freeze Mounjaro. If the pen freezes, throw it away and do not use it.

What clinical results can patients expect?

In large clinical trials, Mounjaro demonstrated significant efficacy for both blood sugar control and weight management:

  • Type 2 Diabetes (SURPASS Program): In trials involving over 5,000 adults over 40 to 52 weeks, tirzepatide produced average HbA1c reductions between -1.87% and -2.59%. Adults on the 15 mg dose achieved average weight reductions ranging from 7.0 kg to 13.9 kg.
  • Weight Loss (SURMOUNT-1 Trial): In a 72-week study of 2,539 adults with obesity or overweight without diabetes, participants taking 5 mg weekly lost an average of 15.0% of their body weight, those on 10 mg lost 19.5%, and those on 15 mg lost 20.9% (22.5 kg), compared to 3.1% on placebo. Up to 91% of adults on the 15 mg dose lost at least 5% of their body weight.

Frequently asked questions

Can I use oral birth control while taking Mounjaro?

Because Mounjaro delays gastric emptying, it can temporarily affect how oral contraceptive pills are absorbed into your body. Patients using oral hormonal contraceptives should switch to a non-oral birth control method or add a barrier method (like condoms) for 4 weeks after starting Mounjaro and for 4 weeks following every dose increase.

What are the most common side effects of Mounjaro?

The most common side effects are gastrointestinal, including nausea (12–22%), diarrhea (12–17%), decreased appetite, vomiting, constipation, and stomach upset. These effects are usually mild to moderate, peak during the initial weeks of dose increases, and tend to taper off once you reach a steady maintenance dose.

Do I need to stop Mounjaro before a planned surgery?

Yes, guidelines from the American Society of Anesthesiologists recommend holding once-weekly GLP-1 and GIP medications for 1 week prior to elective surgeries involving general anesthesia or deep sedation. Because Mounjaro slows stomach emptying, stopping it temporarily reduces the risk of residual stomach contents during surgery.

Who should not take Mounjaro?

Mounjaro is strictly contraindicated in anyone with a personal or family history of Medullary Thyroid Carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). It is also not indicated for patients with type 1 diabetes mellitus or those with a history of severe hypersensitivity to tirzepatide.

What should I do if I am also taking insulin or sulfonylureas?

When starting Mounjaro alongside insulin or a sulfonylurea, your prescribing physician will often lower your background dose of insulin (for instance, reducing basal insulin by 10% to 20% if your HbA1c is under 7.5%) or lower your sulfonylurea dose. This dosage modification is necessary to reduce your risk of developing severe low blood sugar (hypoglycemia).

What signs of serious complications should I watch out for?

You should seek medical care immediately if you experience severe abdominal pain that radiates to your back, which may indicate acute pancreatitis. Additionally, contact your doctor if you experience severe, continuous vomiting or diarrhea, as dehydration from severe stomach side effects can lead to acute kidney injury.

Disclaimer: This article is for educational purposes only and does not replace personalized medical advice, diagnosis, or treatment. To discuss your treatment options or schedule a consultation, contact Professor Dr. Mohammad H. Jamal's clinic on WhatsApp at +965 60621662.

Share this article

Related articles

Have questions about your own health?

Ask the AI Knowledge Center — trained on Professor Jamal's own publications and guidelines — or book a consultation in person.